ArticleScientific reports2021

Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease.

Sergei Pechenov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.